Sotabase

Career

· Research Assistant, University of Wisconsin-Madison2025–
· R&D Engineering Co-op, Protolabs2024–2024
· Teaching Assistant, Carnegie Mellon University2022–
· Bachelor's degree, University of Wisconsin-Madison2021–2025
· High School Diploma, Cherry Hill High School East2017–2021
· Software Engineer, Amazon Web Services (AWS)
· Graduate Student, Carnegie Mellon University
· Intern, Carnegie Mellon University
· Member, Carnegie Mellon University
· Co-founder and Software Engineer, Eulers Bridge
· Owner, Saxvy Pty Ltd
· Co-founder and CTO, Skillest
· Software Engineer, Two Sigma
· Professor, University of California, Davis
· LLM Quality Analyst, University of Florida
· Bachelor of Commerce (B.Com.), University of Melbourne
· Master of Engineering (M.Eng.), University of Melbourne

Publications (277)

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis
Oncogene · 2003
565
cited
Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis
Oncogene · 2004
549
cited
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
Translational Andrology and Urology · 2015
498
cited
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Journal of the National Cancer Institute · 2017
363
cited
Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Clinical Cancer Research · 2014
327
cited
Interleukin‐6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway
The Prostate · 2000
301
cited
Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer.
Cancer Research · 2015
230
cited
Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.
Cancer Research · 2000
224
cited
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
Oncogene · 2014
211
cited
CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.
Cancer Research · 1997
210
cited
Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells.
Clinical Cancer Research · 2003
198
cited
Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer
Nature Genetics · 2005
183
cited
MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth
PLoS ONE · 2012
178
cited
MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells*
Journal of Biological Chemistry · 2011
177
cited
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
Nature Medicine · 2016
169
cited
Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.
Cancer Research · 2010
165
cited
Stat3 activation in prostatic carcinomas
The Prostate · 2002
164
cited
NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants
Molecular Cancer Therapeutics · 2013
157
cited
Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF-κB Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop
Molecular and Cellular Biology · 2012
145
cited
Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
Cancer Research · 1999
139
cited
Sotabase